Salesforce

Measure Paper-CMS 2025 Measure 145v13 for NextGen Office

« Go Back

Information

 
Application Version
Program/Measure Year
Build Version
Document Summary
DomainEffective Clinical Care 
Measure Name CMS 145v13: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) 
 Description  Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF < 40% who were prescribed beta-blocker therapy. 
In the Attachments section of the article, locate the measure paper for NextGen Healthcare Solution.
Attachment 1NextGen Health Quality Measure

 

Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
KeywordseCQM MIPS CMS145 "coronary artery disease" CAD "myocardial infarction" MI beta-blocker "beta blocker" "left ventricular systolic dysfunction" LVEF
TitleMeasure Paper-CMS 2025 Measure 145v13 for NextGen Office
URL NameCMS145

Powered by